tiprankstipranks
Trending News
More News >
Monte Rosa Therapeutics (GLUE)
NASDAQ:GLUE
US Market
Advertisement

Monte Rosa Therapeutics (GLUE) Financial Statements

Compare
328 Followers

Monte Rosa Therapeutics Financial Overview

Monte Rosa Therapeutics's market cap is currently $471.22M. The company's EPS TTM is $-0.15; its P/E ratio is 22.56; Monte Rosa Therapeutics is scheduled to report earnings on August 7, 2025, and the estimated EPS forecast is $-0.36. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Currency in USD

Monte Rosa Therapeutics Earnings and Revenue History

Monte Rosa Therapeutics Debt to Assets

Monte Rosa Therapeutics Cash Flow

Monte Rosa Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis